Biofourmis Gets into Oncology with Gaido Health

Biofourmis Gets into Oncology with Gaido Health

Biofourmis, a privately held global digital therapeutics company, has moved into the oncology arena with its acquisition of Gaido Health from Takeda Pharmaceuticals (NYSE: TAK). Gaido Health is also a digital therapeutics company but exclusively focused on the oncology market. It was part of Takeda Digital Ventures, Takeda’s corporate technology investment, and incubation arm. Financial terms were not disclosed. Boston-based Biofourmis and its Biovitals platform use artificial intelligence (AI) to offer personalized, predictive care for patients. It acquired Swiss wearables firm Biovation AG in November 2019 for an undisclosed price. For Biofourmis, the Gaido Health acquisition seeks... Read More »